U.S. Pharma Stock News

Ferroglobe (NasdaqCM:GSM) opened 2026 with Q1 revenue of US$347.7 million and a basic EPS loss of US$0.04, alongside a trailing 12 month net loss of US$111.3 million on revenue of US$1.4 billion. Over recent quarters the company has seen revenue move between US$307.2 million and US$386.9 million, while quarterly basic EPS has ranged from a loss of US$0.04 to a loss of US$0.43 as profitability remained under pressure and margins stayed in the red. See our full analysis for Ferroglobe. With the...

In late April 2026, Delta Air Lines faced shareholder activism as proposals were filed to introduce cumulative voting and written-consent rights, while the company urged investors to vote against these governance changes in its definitive proxy ahead of the June 18, 2026 annual meeting, and also declared a quarterly dividend of US$0.19 per share payable June 4, 2026. At the same time, Delta has been dealing with widespread flight cancellations, rising jet fuel costs, and service cutbacks on...

BeOne Medicines (ONC) opened 2026 with Q1 revenue of US$1.5b and basic EPS of US$2.05, alongside net income of US$227.4 million. This sets a clear marker for how the business is currently converting its top line into earnings. Over the past year, the company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.5b in Q1 2026, while basic EPS shifted from essentially flat at US$0.01 to US$2.05. This gives investors a straightforward read on how profitability is tracking against the...

Hackett Group (HCKT) has opened Q1 2026 with total revenue of US$67.8 million and basic EPS of US$0.17, alongside trailing twelve month revenue of US$292.5 million and EPS of US$0.53. These figures sit against a net profit margin of 4.8% versus 7.8% a year earlier. Over recent quarters the company has seen quarterly revenue move from US$76.2 million in Q1 2025 to US$77.6 million in Q2 2025, US$72.2 million in Q3 2025 and US$74.8 million in Q4 2025, before landing at US$67.8 million in Q1...

BorgWarner (BWA) opened Q1 2026 with total revenue of US$3.5 billion and basic EPS of US$1.18, setting a clearer earnings picture after a run of mixed quarterly figures that included a Q4 2025 loss. Over the last five reported quarters, revenue has moved in a tight band between US$3.4 billion and US$3.6 billion, while quarterly basic EPS has ranged from a loss of US$1.84 in Q4 2024 to a high of US$1.18 in the latest quarter. The key question for you is how durable these margins look as...

Recent performance snapshot for Boston Beer Company (SAM) Boston Beer Company (SAM) has drawn investor attention after recent share price volatility, with the stock roughly flat over the past day but showing negative returns over the past week, month, and past 3 months. Year to date, the stock shows a small positive total return, while the 1 year, 3 year, and 5 year total returns are negative. This mix of shorter term weakness and modest year to date gain provides the backdrop for evaluating...

Investors may be wondering if Scorpio Tankers at around US$82.56 is still offering value after a strong run, or if most of the opportunity is already priced in. The stock has returned 1.9% over the last week, 7.9% over the last 30 days, 66.2% year to date and 112.4% over the past year. This naturally raises questions about how much risk and reward is now baked into the price. Recent coverage has focused on Scorpio Tankers within the broader oil and gas shipping space, including commentary on...

Viridian Therapeutics recently reported first-quarter 2026 results showing modest revenue of US$141,000 alongside a wider net loss of US$104.9 million, while also launching US$150 million in convertible notes due 2032 and filing a US$100 million follow-on equity offering. At the same time, Viridian released positive Phase 3 REVEAL-2 data for elegrobart in chronic thyroid eye disease and prepared for potential commercialization of veligrotug, signaling a possible shift toward becoming a...

Q1 2026 earnings snapshot and how the story is evolving CompX International (CIX) opened 2026 with Q1 revenue of $40.6 million and basic EPS of $0.47, while trailing 12 month EPS stood at $1.64 on $158.6 million of revenue. Over recent quarters the company has seen revenue move within a tight band from $40.3 million in Q1 2025 to $40.6 million in Q1 2026, with quarterly EPS ranging between $0.34 and $0.47 across that period. This now feeds into a trailing 12 month net income of $20.2 million...

In April and early May 2026, Texas Instruments reported stronger-than-expected Q1 results and issued Q2 revenue guidance of US$5.0 billion to US$5.4 billion with EPS of US$1.77 to US$2.05, highlighting broad-based demand from industrial, data center and AI-related customers. At the same time, a series of routine insider option exercises and share sales by senior executives drew attention to how management is monetizing compensation while the company steps up investment in new fabrication...

UWM Holdings (UWMC) opened 2026 with Q1 revenue of US$752.9 million and basic EPS of US$0.09, alongside trailing twelve month revenue of US$4.0 billion and basic EPS of US$0.27 that reflect the company’s move into profitability over the past year. The company has seen quarterly revenue range from US$613.4 million in Q1 2025 to US$1.0 billion in Q4 2025, with EPS swinging from a loss of US$0.08 in Q1 2025 to a profit of US$0.11 in Q2 2025 before settling at US$0.09 this quarter. This sets up a...

Why PPL (PPL) is on income investors’ radar PPL (PPL) has drawn attention after recent share performance data showed mixed short term moves alongside positive longer term total returns. This has prompted investors to reassess how this regulated utility fits into diversified income focused portfolios. See our latest analysis for PPL. The recent 7 day share price return of -4.60% and 30 day share price return of -4.75% contrast with a 90 day share price return of 3.39% and multi year total...

Lumentum Holdings (LITE) opened Q3 2026 with revenue of US$808.4 million and basic EPS of US$1.99, supported by net income of US$142.5 million. The company has seen revenue move from US$402.2 million in Q2 2025 to US$808.4 million in Q3 2026, while basic EPS shifted from a loss of US$0.88 to a gain of US$1.99. Trailing twelve month EPS stands at US$6.21 on revenue of US$2.5 billion. This combination of profitability and revenue scale puts the focus firmly on margins as results season...

Wondering if Bath & Body Works at around US$19.20 is a bargain or a value trap? This article focuses squarely on what the current price may be implying about the stock. The stock has risen 4.7% over the last week and 6.0% over the last month, yet year to date it shows a 7.4% decline and the 1 year return stands at 34.8% lower. This pattern may catch the eye of value focused investors. Recent coverage around specialty retail and consumer discretionary spending has put companies like Bath &...

On 27 April 2026, LifeStance Health Group, Inc. (NasdaqGS: LFST) was added to the S&P 600, S&P 1000, S&P 600 Health Care, S&P 600 Health Care Services, and the broader S&P Composite 1500 indices. This broad index inclusion strengthens LifeStance’s presence across the U.S. small‑cap and healthcare benchmarks, potentially increasing visibility with institutional and index-tracking investors. Next, we’ll examine how LifeStance’s broad S&P index inclusion shapes its existing investment narrative...

Lineage (LINE) opened Q1 2026 with revenue of US$1.3 billion and a basic EPS loss of US$0.20. On a trailing 12 month basis, revenue stood at US$5.4 billion and basic EPS was a loss of US$0.63, alongside trailing 12 month revenue growth of 4.6% a year versus 11.3% for the broader US market. Over recent quarters, revenue has moved in a narrow band between US$1.29 billion and US$1.38 billion, while quarterly basic EPS has ranged from a loss of US$0.44 to a small profit of roughly US$0.03. This...

Some investors may be considering whether Douglas Dynamics at around US$45.42 is still offering value after a strong run, or whether much of the opportunity is already reflected in the current share price. The stock has recorded returns of 2.8% over 7 days, 8.1% over 30 days, 37.7% year to date and 83.6% over 1 year. This puts recent price action front and center for anyone weighing the balance between potential and risk. Recent coverage has highlighted Douglas Dynamics as a Machinery sector...

Uber Technologies (UBER) opened 2026 with Q1 revenue of US$13.2b and basic EPS of US$0.13, setting the tone for how investors assess profit quality after a year in which trailing twelve month EPS sat at US$4.12. The company reported quarterly revenue increasing from US$11.5b in Q1 2025 to US$13.2b in Q1 2026, while basic EPS moved from US$0.85 to US$0.13 over the same period, against a trailing net income base of US$8.5b. With margins firmly in focus after the past year's compression, this...

Medline (MDLN) opened 2026 by reporting Q1 revenue of about US$7.4b and net income of US$129m, with basic EPS of US$0.16 against a trailing twelve month EPS of US$1.14 that was generated on US$29.1b of revenue and US$966m of net income. Over the past few quarters the company has seen revenue move from US$6.8b in Q4 2024 to US$6.8b in Q1 2025, then to US$7.1b in Q3 2025, US$7.8b in Q4 2025 and finally US$7.4b in Q1 2026, while quarterly basic EPS shifted from US$0.02 in Q4 2024 to US$0.02 in...

If you are wondering whether IPG Photonics at around US$101.94 is a bargain or a potential value trap, you are not alone. The stock has pulled back 10.0% over the last week and 7.7% over the last month, yet it still stands 36.2% higher year to date and 76.1% over the last year, compared with 3-year and 5-year returns of 9.5% and 45.6% declines. Those swings come alongside ongoing attention on IPG Photonics as a key player in high performance fiber lasers and related photonics solutions. This...

CS Disco (LAW) has reported Q1 2026 revenue of US$41.9 million with a basic EPS loss of US$0.15, setting the stage for another quarter where investors are weighing top line progress against ongoing losses. The company has seen quarterly revenue move from US$36.7 million in Q1 2025 to US$41.9 million in Q1 2026, while quarterly basic EPS over that period has ranged from a loss of US$0.19 to a loss of US$0.15, keeping the focus firmly on when margins might begin to meaningfully narrow. With the...

Investors may be wondering if APA at US$38.30 still offers value after a strong run, or if most of the opportunity is already in the price. The stock has a 7 day return of a 5.0% decline and a 30 day return of an 11.0% decline, yet it shows a 51.0% return year to date and 157.7% over the last year, which can change how investors think about both upside and risk. Over the last three and five years, APA has returns of 30.8% and 109.7%. These figures keep the stock on many watchlists even after...

In early May 2026, KKR reported first‑quarter results that beat earnings and revenue estimates, increased its dividend, expanded its share repurchase authorization to US$3.07 billion, and closed the US$1.40 billion acquisition of sports investor Arctos Partners. Together with fresh buyback capacity and growing fee‑earning assets, the Arctos deal signals KKR’s intent to build a broader, sports‑focused investment platform alongside its core alternatives franchise. We’ll now examine how KKR’s...

GXO Logistics (GXO) opened 2026 with Q1 revenue of about US$3.3b and basic EPS of US$0.03, with net income excluding extra items at US$4m, setting a measured tone for investors reviewing the latest print. The company has seen quarterly revenue move from US$3.0b in Q1 2025 to roughly US$3.3b in Q1 2026, while basic EPS shifted from a loss of US$0.81 to a small profit and trailing twelve month EPS reached US$1.15, giving a clearer line of sight on how earnings have tracked across recent...